Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

SHROOM3 DST MYLK MAP1B PPP1R9A FMN2 LMOD1 MICAL3 EPB41L2

6.77e-05479749GO:0003779
GeneOntologyMolecularFunctionmodification-dependent protein binding

RNF168 BRD2 ING2 ZMYND8 ZFAND6 TAF1L

1.16e-04206746GO:0140030
GeneOntologyMolecularFunctionlysine-acetylated histone binding

BRD2 ZMYND8 TAF1L

1.85e-0430743GO:0070577
GeneOntologyMolecularFunctionacetylation-dependent protein binding

BRD2 ZMYND8 TAF1L

2.04e-0431743GO:0140033
GeneOntologyBiologicalProcessDNA damage response

RNF168 UBR5 ING2 RBBP6 BCLAF1 ZMYND8 ZBTB40 NUCKS1 FMN2 RFC1 INTS3 NIPBL HMCES

2.42e-059597213GO:0006974
GeneOntologyBiologicalProcessneurofilament bundle assembly

NEFM NEFH

3.60e-053722GO:0033693
GeneOntologyBiologicalProcessmicrotubule-based movement

NEFM NEFH DST MAP1B ING2 IQCF1 FMN2 ARHGAP21 DYNC1I2

5.30e-05493729GO:0007018
GeneOntologyBiologicalProcesstransport along microtubule

NEFM NEFH DST MAP1B ARHGAP21 DYNC1I2

6.51e-05197726GO:0010970
GeneOntologyBiologicalProcesspositive regulation of dendritic spine development

CDKL5 PPP1R9A CAPRIN2 ZMYND8

1.05e-0470724GO:0060999
GeneOntologyBiologicalProcesscytoskeleton-dependent intracellular transport

NEFM NEFH DST MAP1B ARHGAP21 DYNC1I2

1.35e-04225726GO:0030705
GeneOntologyBiologicalProcessdouble-strand break repair

RNF168 ZMYND8 NUCKS1 FMN2 INTS3 NIPBL HMCES

1.36e-04324727GO:0006302
GeneOntologyCellularComponentnuclear speck

BRD2 CCNB3 RBBP6 BCLAF1 PLCB1 RREB1 THOC2 CWC22 SON

1.87e-05431739GO:0016607
GeneOntologyCellularComponentpostsynaptic intermediate filament cytoskeleton

NEFM NEFH

7.18e-054732GO:0099160
GeneOntologyCellularComponentpostsynaptic cytoskeleton

NEFM NEFH PPP1R9A

1.00e-0426733GO:0099571
GeneOntologyCellularComponentneurofibrillary tangle

NEFM NEFH

1.19e-045732GO:0097418
GeneOntologyCellularComponentpostsynaptic density

NEFM CDKL5 NEFH DST MAP1B PPP1R9A CAST SLC16A7

1.74e-04451738GO:0014069
GeneOntologyCellularComponentasymmetric synapse

NEFM CDKL5 NEFH DST MAP1B PPP1R9A CAST SLC16A7

2.54e-04477738GO:0032279
GeneOntologyCellularComponentcell cortex

SHROOM3 DST PPP1R9A FMN2 MICAL3 EPB41L2 AKAP12

3.12e-04371737GO:0005938
GeneOntologyCellularComponentpostsynaptic specialization

NEFM CDKL5 NEFH DST MAP1B PPP1R9A CAST SLC16A7

3.63e-04503738GO:0099572
GeneOntologyCellularComponentneuron to neuron synapse

NEFM CDKL5 NEFH DST MAP1B PPP1R9A CAST SLC16A7

4.70e-04523738GO:0098984
GeneOntologyCellularComponentbasal dendrite

NEFH MAP1B

5.32e-0410732GO:0097441
GeneOntologyCellularComponentnuclear protein-containing complex

RANBP2 ARID4B PHF20 ING2 BCLAF1 HLF INTS3 THOC2 CWC22 TAF1L NIPBL AFF4 EPB41L2

8.77e-0413777313GO:0140513
GeneOntologyCellularComponentactin cytoskeleton

SHROOM3 DST MYLK PPP1R9A FMN2 LMOD1 ARHGAP21 EPB41L2

8.82e-04576738GO:0015629
GeneOntologyCellularComponentneurofilament

NEFM NEFH

1.07e-0314732GO:0005883
GeneOntologyCellularComponentchromatin

MYCN BRD2 ARID4B PHF20 UBR5 ING2 HLF ZMYND8 PLCB1 NUCKS1 TAF1L NIPBL AFF4

1.69e-0314807313GO:0000785
GeneOntologyCellularComponentintegrator complex

INTS3 NIPBL

2.42e-0321732GO:0032039
GeneOntologyCellularComponentSin3-type complex

ARID4B ING2

2.66e-0322732GO:0070822
GeneOntologyCellularComponentpostsynapse

NEFM CDKL5 NEFH DST MAP1B PPP1R9A ZMYND8 CAST PLCB1 SLC16A7

2.74e-0310187310GO:0098794
DomainBromodomain

BRD2 ZMYND8 TAF1L

3.87e-0438703PF00439
DomainBROMODOMAIN_2

BRD2 ZMYND8 TAF1L

4.85e-0441703PS50014
DomainBROMO

BRD2 ZMYND8 TAF1L

5.21e-0442703SM00297
DomainBromodomain

BRD2 ZMYND8 TAF1L

5.21e-0442703IPR001487
Domain-

BRD2 ZMYND8 TAF1L

5.21e-04427031.20.920.10
DomainEamA_dom

SLC35C1 SLC35F5

1.22e-0314702IPR000620
DomainEamA

SLC35C1 SLC35F5

1.22e-0314702PF00892
DomainZinc_finger_PHD-type_CS

PHF20 ING2 ZMYND8

1.86e-0365703IPR019786
DomainPHD

PHF20 ING2 ZMYND8

2.81e-0375703PF00628
DomainZnf_PHD-finger

PHF20 ING2 ZMYND8

3.25e-0379703IPR019787
DomainBromodomain_CS

BRD2 TAF1L

4.25e-0326702IPR018359
DomainPHD

PHF20 ING2 ZMYND8

4.55e-0389703SM00249
DomainTUDOR

ARID4B PHF20

4.57e-0327702SM00333
DomainZnf_PHD

PHF20 ING2 ZMYND8

4.84e-0391703IPR001965
DomainZF_PHD_2

PHF20 ING2 ZMYND8

5.46e-0395703PS50016
DomainZF_PHD_1

PHF20 ING2 ZMYND8

5.62e-0396703PS01359
DomainTudor

ARID4B PHF20

5.63e-0330702IPR002999
Domain-

RNF168 SH3RF1 PHF20 ING2 RBBP6 ZMYND8

6.69e-034497063.30.40.10
DomainZnf_RING/FYVE/PHD

RNF168 SH3RF1 PHF20 ING2 RBBP6 ZMYND8

7.43e-03459706IPR013083
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

MYCN RANBP2 BRD2 ARID4B RBBP6 BCLAF1 ZMYND8 CAST ZBTB40 NUCKS1 MICAL3 RFC1 RREB1 INTS3 THOC2 NIPBL DYNC1I2 EPB41L2 RPRD1B SON

1.33e-16774742015302935
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

USP14 RANBP2 DST MAP1B RBBP6 BCLAF1 ZMYND8 CAST NUCKS1 RFC1 THOC2 WNK1 NIPBL ARHGAP21 AFF4 EPB41L2 AKAP12 SON

7.95e-13934741833916271
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

RANBP2 BRD2 ARID4B MAP1B RBBP6 BCLAF1 ZMYND8 CAST RFC1 RREB1 THOC2 CWC22 TAF1L NIPBL AFF4 SON

1.38e-10954741636373674
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

RANBP2 DST RNF168 BRD2 ARID4B PHF20 ING2 RBBP6 BCLAF1 ZMYND8 RFC1 RREB1 INTS3 THOC2 TAF1L NIPBL RPRD1B SON

1.67e-101294741830804502
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

NEFM NEFH RANBP2 SHROOM3 DST UBR5 BCLAF1 PPP1R9A HECTD4 PLCB1 NIPBL ARHGAP21 AFF4 EPB41L2 AKAP12

1.54e-09963741528671696
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

NEFM RANBP2 DST BRD2 MAP1B RBBP6 BCLAF1 ZMYND8 HECTD4 NUCKS1 THOC2 CWC22 NIPBL AFF4 SON

7.37e-091082741538697112
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

USP14 RANBP2 RNF168 BRD2 UBR5 RBBP6 BCLAF1 ZMYND8 NUCKS1 RFC1 THOC2 NIPBL RPRD1B SON

2.63e-081014741432416067
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

RANBP2 ARID4B ING2 BCLAF1 ZMYND8 RFC1 RREB1 INTS3 THOC2 EPB41L2 SON

4.30e-08583741129844126
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CYLC2 NEFM EFCAB5 RANBP2 DST BRD2 MYLK MAP1B CCDC47 BCLAF1 PPP1R9A SEC62 CAPRIN2 NIPBL ARHGAP21 DYNC1I2

4.87e-081442741635575683
Pubmed

The intermediate filament protein peripherin is the specific interaction partner of mouse BPAG1-n (dystonin) in neurons.

NEFM NEFH DST

9.22e-0857439971739
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

RANBP2 RBBP6 BCLAF1 NUCKS1 RFC1 THOC2 WNK1 NIPBL EPB41L2 SON

1.15e-07503741016964243
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

USP14 RBBP6 BCLAF1 ZMYND8 RFC1 THOC2 TAF1L AFF4

1.65e-0728374830585729
Pubmed

Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.

RANBP2 DST CCDC47 BCLAF1 SEC62 EPB41L2 AKAP12

1.78e-0719174731177093
Pubmed

Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

NEFM NEFH MAP1B

5.14e-07874321486449
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

RANBP2 RNF168 MAP1B RBBP6 HECTD4 RFC1 SON

1.09e-0625074733536335
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

RANBP2 DST ZBTB40 NUCKS1 WNK1 ARHGAP21 AKAP12 SON SLC35F5

1.12e-0649774923414517
Pubmed

The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.

ARID4B MAP1B UBR5 ING2 SLC35C1 WNK1 SON

1.18e-0625374729911972
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NEFM RANBP2 DST MAP1B UBR5 RFC1 THOC2 NIPBL EPB41L2 SON

1.24e-06653741022586326
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

RANBP2 BRD2 MAP1B ZMYND8 RFC1 DYNC1I2 EPB41L2 RPRD1B

1.98e-0639474827248496
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

NEFH USP14 DST BRD2 UBR5 BCLAF1 CAST RFC1 RPRD1B

2.15e-0653874928524877
Pubmed

Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.

BRD2 MAP1B RBBP6 BCLAF1 WNK1 EPB41L2 RPRD1B SON

2.18e-0639974835987950
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

RANBP2 DST SH3RF1 MAP1B CCDC47 BCLAF1 MICAL3 ARHGAP21 EPB41L2 AKAP12

2.55e-06708741039231216
Pubmed

The functional interactome landscape of the human histone deacetylase family.

ARID4B UBR5 ING2 BCLAF1 ZMYND8 RREB1 SON

2.85e-0628974723752268
Pubmed

A comprehensive resource of interacting protein regions for refining human transcription factor networks.

NEFM ARID4B MAP1B SEC62 ARHGAP21 AKAP12

3.44e-0619174620195357
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

USP14 RANBP2 UBR5 DOCK8 BCLAF1 ZMYND8 ZBTB40 NUCKS1 RFC1 RREB1 THOC2 NIPBL

3.50e-061103741234189442
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

RANBP2 ZCCHC10 ING2 RBBP6 CCDC47 ZMYND8 RFC1 RREB1 INTS3 THOC2 CWC22 NIPBL SON

3.82e-061318741330463901
Pubmed

The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit.

NEFM NEFH

4.47e-06274216246456
Pubmed

The C-terminal domains of NF-H and NF-M subunits maintain axonal neurofilament content by blocking turnover of the stationary neurofilament network.

NEFM NEFH

4.47e-06274223028520
Pubmed

Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.

NEFM NEFH

4.47e-06274216002469
Pubmed

Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

NEFM NEFH

4.47e-06274220624930
Pubmed

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

USP14 IDO1

4.47e-06274236163134
Pubmed

Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit.

NEFM NEFH

4.47e-06274210402469
Pubmed

Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.

DST MAP1B

4.47e-06274222412020
Pubmed

Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments.

NEFM NEFH

4.47e-06274217498690
Pubmed

UBR5 is a novel regulator of WNK1 stability.

UBR5 WNK1

4.47e-06274235442829
Pubmed

Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs.

NEFM NEFH

4.47e-06274230029677
Pubmed

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma.

MYCN DST

4.47e-06274234116676
Pubmed

CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells.

MYCN CDKL5

4.47e-06274222921766
Pubmed

Hypophosphorylation of NF-H and NF-M subunits of neurofilaments and the associated decrease in KSPXK kinase activity in the sciatic nerves of swiss white mice inoculated in the foot pad with mycobacterium leprae.

NEFM NEFH

4.47e-06274220306637
Pubmed

Mice with disrupted midsized and heavy neurofilament genes lack axonal neurofilaments but have unaltered numbers of axonal microtubules.

NEFM NEFH

4.47e-06274210397632
Pubmed

Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

NEFM NEFH

4.47e-06274221828286
Pubmed

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.

NEFM NEFH

4.47e-06274211733539
Pubmed

Characterization of two proteolytically derived soluble polypeptides from the neurofilament triplet components NFM and NFH.

NEFM NEFH

4.47e-0627422557834
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

SHROOM3 DST SH3RF1 UBR5 DOCK8 PPP1R9A THOC2 WNK1

4.94e-0644674824255178
Pubmed

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.

MAP1B AEBP1 UBR5 LMOD1 RWDD4

5.07e-0611674530652415
Pubmed

Proteomic analysis of in vivo phosphorylated synaptic proteins.

NEFM MAP1B PLCB1 FMN2

5.11e-065374415572359
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

NEFM RANBP2 DST MAP1B UBR5 CAST NUCKS1 MICAL3 RFC1 DYNC1I2 EPB41L2 AKAP12

5.30e-061149741235446349
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

USP14 RANBP2 MAP1B CCDC47 BCLAF1 NUCKS1 RFC1 INTS3 WNK1 DYNC1I2 AKAP12 RPRD1B SON

5.67e-061367741332687490
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

RANBP2 UBR5 BCLAF1 RFC1 NIPBL SON

5.94e-0621074616565220
Pubmed

An Interaction Landscape of Ubiquitin Signaling.

USP14 DST RNF168 ZCCHC10 UBR5 HECTD4 ZFAND6 RFC1

8.56e-0648174828190767
Pubmed

A human MAP kinase interactome.

RANBP2 DST SH3RF1 ARID4B RBBP6 PLCB1 WNK1 EPB41L2

9.23e-0648674820936779
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

DST BRD2 ARID4B MAP1B BCLAF1 MICAL3 RFC1 THOC2 WNK1

9.28e-0664574925281560
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

NEFM NEFH DST MAP1B PLCB1 FMN2 MICAL3

9.40e-0634774717114649
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

RANBP2 DST BRD2 MAP1B UBR5 BCLAF1 PPP1R9A THOC2 NIPBL EPB41L2 SON

1.05e-051024741124711643
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

DST BCLAF1 PPP1R9A MICAL3 NIPBL DYNC1I2 AKAP12

1.19e-0536074733111431
Pubmed

Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.

CDKL5 BCLAF1 PPP1R9A ARHGAP21 EPB41L2 RPRD1B SON

1.21e-0536174730344098
Pubmed

Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.

NEFM MAP1B MICAL3 ARHGAP21

1.31e-056774429254152
Pubmed

Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits.

NEFM NEFH

1.34e-05374210461886
Pubmed

Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

NEFM NEFH

1.34e-05374211050249
Pubmed

Sequence and structure of the mouse gene coding for the largest neurofilament subunit.

NEFM NEFH

1.34e-0537423220257
Pubmed

Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization.

NEFM MAP1B

1.34e-05374211581286
Pubmed

Neurofilament homeostasis and motoneurone degeneration.

NEFM NEFH

1.34e-05374211135306
Pubmed

Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.

NEFM NEFH

1.34e-05374216084104
Pubmed

Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits.

NEFM NEFH

1.34e-0537427790359
Pubmed

Expression of the mouse Macf2 gene during inner ear development.

NEFM DST

1.34e-05374212399109
Pubmed

Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein.

NEFM NEFH

1.34e-0537428110465
Pubmed

Neurofilaments and motor neuron disease.

NEFM NEFH

1.34e-05374217708953
Pubmed

Neurofilaments bind tubulin and modulate its polymerization.

NEFM NEFH

1.34e-05374219726663
Pubmed

Negative regulatory regions are present upstream in the three mouse neurofilament genes.

NEFM NEFH

1.34e-0537421315909
Pubmed

Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis.

NEFM NEFH

1.34e-05374232189712
Pubmed

Methylation and expression of neurofilament genes in tissues and in cell lines of the mouse.

NEFM NEFH

1.34e-0537428510499
Pubmed

Axonal atrophy in aging is associated with a decline in neurofilament gene expression.

NEFM NEFH

1.34e-0537427563228
Pubmed

The scaffold protein POSH regulates axon outgrowth.

SHROOM3 SH3RF1

1.34e-05374218829867
Pubmed

POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66.

SHROOM3 SH3RF1

1.34e-05374220926658
Pubmed

Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs.

NEFM NEFH

1.34e-0537428575331
Pubmed

NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth.

NEFM NEFH

1.34e-05374214662745
Pubmed

Cloning and developmental expression of the murine neurofilament gene family.

NEFM NEFH

1.34e-0537423103856
Pubmed

Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic degeneration in dystonia musculorum mice.

NEFH DST

1.34e-0537429242412
Pubmed

MAP1B and clathrin are novel interacting partners of the giant cyto-linker dystonin.

DST MAP1B

1.34e-05374221936565
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

MYCN NEFM RANBP2 ARID4B MAP1B UBR5 ING2 ZMYND8 ZBTB40 INTS3

1.35e-05857741025609649
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RANBP2 SHROOM3 DST BRD2 RBBP6 CCDC47 PPP1R9A ZMYND8 TAF1L NIPBL AFF4 EPB41L2 SON

1.49e-051497741331527615
Pubmed

Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.

NEFM NEFH UBR5 PPP1R9A PLCB1 EPB41L2

1.64e-0525174627507650
Pubmed

HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.

BCLAF1 ZMYND8 NUCKS1 AFF4 SON

1.66e-0514874532538781
Pubmed

ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.

RANBP2 BRD2 ARID4B ZMYND8 NIPBL

1.77e-0515074528242625
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

DST UBR5 RBBP6 CCDC47 SEC62 RFC1 WNK1 NIPBL PGM2 EPB41L2 AKAP12 RPRD1B

1.78e-051297741233545068
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

BRD2 ZMYND8 RFC1 INTS3 THOC2 CWC22 NIPBL EPB41L2

1.79e-0553374830554943
Pubmed

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.

USP14 RANBP2 UBR5 CCDC47 THOC2 WNK1 HMCES EPB41L2

1.82e-0553474835032548
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

RANBP2 MAP1B UBR5 CCDC47 ZMYND8 NIPBL DYNC1I2 EPB41L2 SON

1.85e-0570474929955894
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

BRD2 ARID4B UBR5 CCNB3 RBBP6 CAPRIN2 ZMYND8 FMN2 RREB1 AFF4 SON

2.32e-051116741131753913
Pubmed

Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.

RANBP2 MAP1B UBR5 CCDC47 ARHGAP21 DYNC1I2 AKAP12

2.66e-0540874733766124
Pubmed

How the projection domains of NF-L and alpha-internexin determine the conformations of NF-M and NF-H in neurofilaments.

NEFM NEFH

2.67e-05474220213320
Pubmed

Recruitment of the cohesin loading factor NIPBL to DNA double-strand breaks depends on MDC1, RNF168 and HP1γ in human cells.

RNF168 NIPBL

2.67e-05474221784059
Pubmed

Chromosomal location of N-myc and L-myc genes in the mouse.

MYCN PGM2

2.67e-0547422654812
Pubmed

USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination.

USP14 RNF168

2.67e-05474229995557
Pubmed

RE1 silencing transcription factor is involved in regulating neuron-specific expression of alpha-internexin and neurofilament genes.

NEFM NEFH

2.67e-05474219457133
Pubmed

Mice lacking brain-derived neurotrophic factor develop with sensory deficits.

NEFM NEFH

2.67e-0547428139657
Pubmed

Neurofilament transport in vivo minimally requires hetero-oligomer formation.

NEFM NEFH

2.67e-05474214561875
Pubmed

Cx43 gap junction gene expression and gap junctional communication in mouse neural crest cells.

NEFM NEFH

2.67e-0547429144923
Pubmed

Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes in wobbler neuromuscular disease.

NEFM NEFH

2.67e-05474211493023
Pubmed

The toppler mouse: a novel mutant exhibiting loss of Purkinje cells.

NEFM NEFH

2.67e-05474215248193
InteractionNAA40 interactions

USP14 RANBP2 DST MAP1B RBBP6 BCLAF1 ZMYND8 CAST NUCKS1 RFC1 THOC2 WNK1 NIPBL ARHGAP21 AFF4 EPB41L2 AKAP12 SON

8.36e-099787318int:NAA40
InteractionSMC5 interactions

RANBP2 BRD2 ARID4B MAP1B RBBP6 BCLAF1 ZMYND8 CAST RFC1 RREB1 THOC2 CWC22 TAF1L NIPBL AFF4 SON

4.38e-0710007316int:SMC5
InteractionCALD1 interactions

NEFM DST ARID4B DOCK8 PPP1R9A SEC62 LMOD1 MICAL3 EPB41L2

4.78e-07265739int:CALD1
InteractionMECP2 interactions

MYCN NEFM CDKL5 RANBP2 DST BRD2 MAP1B RBBP6 BCLAF1 ZMYND8 HECTD4 NUCKS1 THOC2 CWC22 NIPBL AFF4 EPB41L2 SON

5.27e-0712877318int:MECP2
InteractionSSRP1 interactions

MYCN USP14 RANBP2 BRD2 UBR5 RBBP6 BCLAF1 ZMYND8 RFC1 INTS3 NIPBL RPRD1B SON

9.52e-076857313int:SSRP1
InteractionTOP1 interactions

MYCN USP14 BRD2 ARID4B UBR5 RBBP6 BCLAF1 ZMYND8 RFC1 INTS3 NIPBL RPRD1B SON

1.14e-066967313int:TOP1
InteractionH2BC21 interactions

RNF168 BRD2 ARID4B MAP1B ZCCHC10 BCLAF1 ZMYND8 NUCKS1 RFC1 RREB1 INTS3 NIPBL RPRD1B

1.14e-066967313int:H2BC21
InteractionCDC5L interactions

MYCN RANBP2 SHROOM3 DST BRD2 ZCCHC10 UBR5 DOCK8 RBBP6 INTS3 THOC2 CWC22 NIPBL SON

1.98e-068557314int:CDC5L
InteractionDDX41 interactions

MYCN BRD2 ARID4B MAP1B UBR5 THOC2 CWC22

2.34e-06166737int:DDX41
InteractionMYH9 interactions

MYCN NEFM NEFH USP14 SHROOM3 DST MYLK MAP1B MICAL3 WNK1 ARHGAP21 DYNC1I2 EPB41L2

2.75e-067547313int:MYH9
InteractionFMR1 interactions

MYCN CDKL5 USP14 RANBP2 MAP1B RBBP6 BCLAF1 ZMYND8 NIPBL ARHGAP21 AFF4

3.41e-065367311int:FMR1
InteractionCAMKV interactions

BRD2 ZCCHC10 BCLAF1 CWC22 AFF4 EPB41L2

4.38e-06118736int:CAMKV
InteractionCIC interactions

RANBP2 ARID4B ING2 BCLAF1 SEC62 ZMYND8 RFC1 RREB1 INTS3 THOC2 EPB41L2 SON

4.97e-066737312int:CIC
InteractionDDX23 interactions

MYCN NEFM BRD2 MAP1B UBR5 RBBP6 BCLAF1 THOC2 CWC22 AFF4

8.68e-064807310int:DDX23
InteractionWDR76 interactions

RANBP2 BRD2 MAP1B ZMYND8 RFC1 INTS3 DYNC1I2 EPB41L2 RPRD1B

9.78e-06383739int:WDR76
InteractionKCNA3 interactions

RANBP2 DST SH3RF1 MAP1B RBBP6 CCDC47 BCLAF1 CAPRIN2 MICAL3 THOC2 ARHGAP21 EPB41L2 AKAP12

1.31e-058717313int:KCNA3
InteractionNUP43 interactions

RANBP2 DST ARID4B UBR5 RBBP6 BCLAF1 ZMYND8 RFC1 CWC22 NIPBL SON

1.45e-056257311int:NUP43
InteractionCDK12 interactions

MYCN ZCCHC10 UBR5 BCLAF1 THOC2 CWC22 AFF4

1.87e-05228737int:CDK12
InteractionPRP4K interactions

MYCN BRD2 ZCCHC10 UBR5 BCLAF1 NUCKS1 THOC2 CWC22

2.48e-05329738int:PRP4K
InteractionTERF2IP interactions

IDO1 RBBP6 ZMYND8 NUCKS1 RFC1 RREB1 THOC2 NIPBL AFF4 RPRD1B

2.89e-055527310int:TERF2IP
InteractionUBC interactions

USP14 DST RNF168 ZCCHC10 UBR5 BCLAF1 HECTD4 ZFAND6 RFC1

3.25e-05446739int:UBC
InteractionRPS6KL1 interactions

RANBP2 MAP1B UBR5 SON

3.48e-0551734int:RPS6KL1
InteractionLYN interactions

USP14 DST BRD2 SH3RF1 PPP1R9A PLCB1 FMN2 MICAL3 ARHGAP21 EPB41L2 AKAP12

5.30e-057207311int:LYN
InteractionHMGXB4 interactions

MYCN BRD2 ARID4B ZCCHC10 UBR5

5.62e-05113735int:HMGXB4
InteractionH2AZ1 interactions

USP14 RNF168 BRD2 ARID4B ZMYND8 NUCKS1 RFC1 AFF4

5.80e-05371738int:H2AZ1
InteractionEPB41L1 interactions

BRD2 ZCCHC10 CAST CWC22 AFF4 EPB41L2

5.99e-05187736int:EPB41L1
InteractionPOLR1G interactions

MYCN BRD2 ARID4B ZMYND8 RFC1 RREB1 NIPBL AFF4 RPRD1B

6.63e-05489739int:POLR1G
InteractionBRD9 interactions

MYCN BRD2 ZCCHC10 CWC22 EPB41L2

6.63e-05117735int:BRD9
InteractionZMYND8 interactions

MYCN BRD2 ZCCHC10 ZMYND8 RREB1 INTS3

6.73e-05191736int:ZMYND8
InteractionPFN1 interactions

USP14 RANBP2 DOCK8 FMN2 MICAL3 WNK1 ARHGAP21 AFF4 RPRD1B

9.01e-05509739int:PFN1
InteractionSNRNP40 interactions

MYCN USP14 UBR5 RBBP6 BCLAF1 RFC1 CWC22 HMCES EPB41L2 SON

9.58e-056377310int:SNRNP40
InteractionPSIP1 interactions

MYCN USP14 BRD2 CAST NUCKS1 SON

9.94e-05205736int:PSIP1
InteractionH2BC3 interactions

RANBP2 RNF168 BRD2 MAP1B ZMYND8 RFC1 DYNC1I2 RPRD1B

1.08e-04406738int:H2BC3
InteractionPNN interactions

MYCN BRD2 RBBP6 BCLAF1 CWC22 DYNC1I2 EPB41L2

1.11e-04302737int:PNN
InteractionDBN1 interactions

DST RNF168 BRD2 UBR5 PPP1R9A NIPBL ARHGAP21 DYNC1I2

1.30e-04417738int:DBN1
InteractionSNIP1 interactions

MYCN BRD2 ZCCHC10 BCLAF1 CWC22 NIPBL EPB41L2 SON

1.30e-04417738int:SNIP1
InteractionDHX9 interactions

MYCN NEFM USP14 RANBP2 RNF168 ZMYND8 PLCB1 THOC2 NIPBL SON

1.31e-046627310int:DHX9
InteractionC11orf52 interactions

DST PLCB1 FMN2 MICAL3 ARHGAP21 EPB41L2 AKAP12

1.33e-04311737int:C11orf52
InteractionHDAC1 interactions

MYCN NEFM RANBP2 DST ARID4B UBR5 ING2 CCDC47 ZMYND8 NUCKS1 RFC1 RREB1 ARHGAP21

1.55e-0411087313int:HDAC1
InteractionCWC22 interactions

MYCN SEC62 THOC2 CWC22 EPB41L2

1.60e-04141735int:CWC22
InteractionGAPDH interactions

MYCN USP14 RANBP2 MAP1B SEC62 RFC1 NIPBL ARHGAP21 AFF4 AKAP12

1.75e-046867310int:GAPDH
InteractionRPL22 interactions

MYCN USP14 MAP1B ZCCHC10 CCDC47 ZMYND8 NUCKS1 CWC22

1.88e-04440738int:RPL22
InteractionPRPF40A interactions

MYCN ZCCHC10 UBR5 NUCKS1 THOC2 CWC22 EPB41L2 SON

2.06e-04446738int:PRPF40A
InteractionZNF330 interactions

BRD2 ARID4B ZMYND8 RFC1 RREB1 NIPBL RWDD4 AFF4

2.06e-04446738int:ZNF330
InteractionAR interactions

TGFB1I1 USP14 BRD2 UBR5 ING2 ZMYND8 HECTD4 RREB1 NIPBL AFF4 RPRD1B SON

2.17e-049927312int:AR
InteractionPOLDIP3 interactions

MYCN BRD2 UBR5 BCLAF1 THOC2 NIPBL

2.19e-04237736int:POLDIP3
InteractionRAB35 interactions

DST CCDC47 PPP1R9A PLCB1 FMN2 MICAL3 ARHGAP21 EPB41L2 AKAP12

2.19e-04573739int:RAB35
InteractionMED4 interactions

DST MAP1B ZCCHC10 UBR5 BCLAF1 MICAL3 THOC2 WNK1

2.19e-04450738int:MED4
InteractionH2BC8 interactions

BRD2 ARID4B CCDC47 ZMYND8 NUCKS1 RFC1 RREB1 INTS3 NIPBL

2.28e-04576739int:H2BC8
InteractionARRB2 interactions

RANBP2 BRD2 MAP1B UBR5 BCLAF1 ARHGAP21 ALPK2 AFF4

2.33e-04454738int:ARRB2
InteractionPHF21A interactions

NEFM RANBP2 DST UBR5 ZMYND8 RREB1 ARHGAP21

2.42e-04343737int:PHF21A
InteractionCOL17A1 interactions

RANBP2 DST NUCKS1

2.52e-0434733int:COL17A1
InteractionHMG20A interactions

MYCN ARID4B ZMYND8 NUCKS1 RREB1 RPRD1B

2.56e-04244736int:HMG20A
InteractionSRRM2 interactions

MYCN MAP1B ZCCHC10 RBBP6 CWC22 DYNC1I2 EPB41L2 SON

2.62e-04462738int:SRRM2
InteractionSRRM1 interactions

MYCN USP14 RANBP2 BRD2 ZCCHC10 UBR5 BCLAF1

2.64e-04348737int:SRRM1
InteractionMICAL2 interactions

MYCN DST MICAL3

2.75e-0435733int:MICAL2
InteractionSUMO2 interactions

RANBP2 DST RNF168 ZMYND8 CAST RREB1 INTS3 NIPBL RPRD1B

2.75e-04591739int:SUMO2
InteractionKPNA3 interactions

MYCN RANBP2 MAP1B ZCCHC10 ZMYND8 DYNC1I2

2.79e-04248736int:KPNA3
InteractionLUC7L2 interactions

MYCN USP14 ZCCHC10 UBR5 DOCK8 BCLAF1 DYNC1I2

2.88e-04353737int:LUC7L2
InteractionDENND2D interactions

BRD2 CWC22 AFF4

2.99e-0436733int:DENND2D
InteractionGAN interactions

NEFM NEFH DST MAP1B BCLAF1 PLCB1

3.11e-04253736int:GAN
InteractionMECOM interactions

BRD2 MAP1B PPP1R9A RFC1 THOC2 DYNC1I2 SON

3.14e-04358737int:MECOM
InteractionPPP1CC interactions

CDKL5 USP14 UBR5 BCLAF1 PPP1R9A DYRK4 ARHGAP21 EPB41L2 RPRD1B SON

3.15e-047387310int:PPP1CC
InteractionPRKD2 interactions

DST MAP1B AEBP1 UBR5 LMOD1 RWDD4

3.18e-04254736int:PRKD2
InteractionMDK interactions

MYCN BRD2 CWC22 AFF4

3.34e-0491734int:MDK
InteractionSIRT7 interactions

NEFM RANBP2 DST MAP1B UBR5 RFC1 THOC2 NIPBL EPB41L2 SON

3.36e-047447310int:SIRT7
InteractionSMARCB1 interactions

MYCN BRD2 ARID4B UBR5 ING2 NUCKS1 SON

3.47e-04364737int:SMARCB1
InteractionTAF1 interactions

RANBP2 BRD2 PHF20 ZCCHC10 UBR5 TAF1L

3.60e-04260736int:TAF1
InteractionRHBDF2 interactions

RANBP2 DST CCDC47 EPB41L2 AKAP12

3.61e-04168735int:RHBDF2
InteractionNFKBIL1 interactions

BRD2 ZCCHC10 CWC22 AFF4

3.63e-0493734int:NFKBIL1
InteractionKIF20A interactions

NEFM RANBP2 SHROOM3 UBR5 RBBP6 BCLAF1 PPP1R9A HECTD4 NUCKS1 THOC2 PGM2 SON

3.70e-0410527312int:KIF20A
InteractionH3C1 interactions

CYLC2 BRD2 ARID4B PHF20 CCNB3 ZMYND8 CAST NUCKS1 RFC1 NIPBL AFF4

3.77e-049017311int:H3C1
InteractionPIP4K2B interactions

RANBP2 BRD2 ZCCHC10 RPRD1B

4.09e-0496734int:PIP4K2B
InteractionRCOR1 interactions

NEFM RANBP2 DST UBR5 ZMYND8 NUCKS1 RREB1 ARHGAP21

4.10e-04494738int:RCOR1
InteractionCALM1 interactions

MYCN RANBP2 DST MYLK UBR5 WNK1 HMCES ARHGAP21 RPRD1B

4.19e-04626739int:CALM1
InteractionSLFN11 interactions

RANBP2 RNF168 MAP1B RBBP6 HECTD4 RFC1 SON

4.21e-04376737int:SLFN11
InteractionRNF168 interactions

USP14 RNF168 UBR5 RPRD1B

4.43e-0498734int:RNF168
InteractionARGLU1 interactions

MYCN RANBP2 ZCCHC10 UBR5 BCLAF1

4.46e-04176735int:ARGLU1
InteractionNR2C2 interactions

RANBP2 SH3RF1 ZCCHC10 ING2 RBBP6 CCDC47 ZMYND8 RFC1 RREB1 INTS3 THOC2 CWC22 NIPBL SON

4.47e-0414037314int:NR2C2
InteractionAKAP17A interactions

DST BRD2 ZCCHC10 UBR5

4.60e-0499734int:AKAP17A
InteractionH2BC20P interactions

MYCN HECTD4 ZBTB40

4.73e-0442733int:H2BC20P
InteractionLAMP1 interactions

CDKL5 DST CCDC47 PPP1R9A PLCB1 FMN2 ARHGAP21 EPB41L2 AKAP12

5.15e-04644739int:LAMP1
InteractionCBX3 interactions

MYCN USP14 BRD2 RBBP6 ZMYND8 NUCKS1 RFC1 RREB1 NIPBL

5.26e-04646739int:CBX3
InteractionFLNA interactions

MYCN USP14 RANBP2 MAP1B SEC62 CAPRIN2 NIPBL ARHGAP21 AKAP12

5.38e-04648739int:FLNA
InteractionTPR interactions

MYCN RANBP2 DOCK8 SEC62 CAST EPB41L2

5.42e-04281736int:TPR
InteractionSNRNP27 interactions

MYCN UBR5 THOC2 CWC22 RPRD1B

5.46e-04184735int:SNRNP27
InteractionZCCHC17 interactions

MYCN ZCCHC10 UBR5 ZMYND8

5.54e-04104734int:ZCCHC17
InteractionPOTEI interactions

MYCN USP14 RBBP6 EPB41L2

5.75e-04105734int:POTEI
InteractionRGS12 interactions

RBBP6 PLCB1 DYNC1I2

5.80e-0445733int:RGS12
InteractionAPEX1 interactions

TGFB1I1 BRD2 ARID4B ZCCHC10 ZMYND8 PLCB1 RFC1 RREB1 THOC2 NIPBL DYNC1I2 AFF4 EPB41L2

5.84e-0412717313int:APEX1
InteractionEED interactions

MYCN USP14 RANBP2 SHROOM3 ARID4B MAP1B RBBP6 BCLAF1 NUCKS1 INTS3 THOC2 CWC22 NIPBL SON

6.01e-0414457314int:EED
InteractionGSPT2 interactions

MYCN UBR5 RBBP6 BCLAF1

6.17e-04107734int:GSPT2
InteractionCPSF6 interactions

MYCN ZCCHC10 RBBP6 BCLAF1 CWC22 DYNC1I2 RPRD1B SON

6.20e-04526738int:CPSF6
InteractionACTL6A interactions

MYCN BRD2 ARID4B UBR5 ING2 RPRD1B

6.28e-04289736int:ACTL6A
InteractionNEFM interactions

MYCN NEFM NEFH MAP1B RPRD1B

6.32e-04190735int:NEFM
InteractionTAF9B interactions

MYCN BRD2 ZCCHC10 TAF1L

6.39e-04108734int:TAF9B
InteractionPRPF3 interactions

MYCN BRD2 MAP1B ZCCHC10 CWC22 SON

6.51e-04291736int:PRPF3
InteractionDHX8 interactions

ZCCHC10 RBBP6 BCLAF1 CWC22 AFF4 SON

6.63e-04292736int:DHX8
InteractionCAVIN1 interactions

BRD2 MAP1B ZCCHC10 UBR5 ARHGAP21 EPB41L2

6.63e-04292736int:CAVIN1
InteractionMINK1 interactions

NEFM CDKL5 MAP1B ZCCHC10 UBR5

6.78e-04193735int:MINK1
Cytoband4q35.1

ING2 RWDD4

1.56e-03367424q35.1
GeneFamilyIntermediate filaments Type IV

NEFM NEFH

9.03e-056452611
GeneFamilyPHD finger proteins

PHF20 ING2 ZMYND8

1.46e-039045388
CoexpressionTOMLINS_PROSTATE_CANCER_DN

TGFB1I1 DST MYLK AKAP12

4.95e-0640744M11504
CoexpressionCHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN

TGFB1I1 MYLK MAP1B ZC3H12C SLC16A7 ARHGAP21 ALPK2 EPB41L2 AKAP12

6.42e-06465749M9192
CoexpressionLIU_PROSTATE_CANCER_DN

TGFB1I1 NEFH DST MYLK MAP1B AEBP1 HLF LMOD1 AKAP12

1.02e-05493749M19391
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

DST MYLK MAP1B AEBP1 RBBP6 HLF ZMYND8 HECTD4 FMN2 MICAL3 THOC2 SLC16A7 EPB41L2

1.15e-0511027413M2369
CoexpressionWANG_TUMOR_INVASIVENESS_UP

NEFM USP14 SHROOM3 BRD2 CCDC47 SEC62 NUCKS1 RFC1

1.28e-05384748M1865
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

DST MYLK MAP1B AEBP1 RBBP6 HLF ZMYND8 HECTD4 FMN2 MICAL3 THOC2 SLC16A7 EPB41L2

1.42e-0511247413MM1070
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

ARID4B CCDC47 BCLAF1 SEC62 CAPRIN2 CAST RFC1 SLC16A7 NIPBL SON

1.53e-056567410M18979
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

SHROOM3 ARID4B MAP1B BCLAF1 SEC62 NUCKS1 RWDD4 EPB41L2 SON

1.54e-05519749M3395
CoexpressionWANG_TUMOR_INVASIVENESS_UP

NEFM USP14 SHROOM3 BRD2 CCDC47 SEC62 NUCKS1 RFC1

1.78e-05402748MM1248
CoexpressionGSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN

SH3RF1 IDO1 BCLAF1 CAPRIN2 NIPBL AKAP12

2.14e-05199746M5632
CoexpressionMARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN

SHROOM3 ARID4B MAP1B BCLAF1 SEC62 NUCKS1 RWDD4 EPB41L2 SON

2.20e-05543749MM997
CoexpressionFAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2

TGFB1I1 MYLK AEBP1 ING2 NUCKS1 RWDD4 AKAP12

2.24e-05300747M41708
CoexpressionFAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL

TGFB1I1 BRD2 MYLK MAP1B NUCKS1 LMOD1 DYNC1I2

2.54e-05306747M41716
CoexpressionMENON_FETAL_KIDNEY_4_PODOCYTES

DST BRD2 PPP1R9A SEC62 CAST RFC1

2.60e-05206746M39254
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

RANBP2 DST PHF20 MAP1B UBR5 ZMYND8 MICAL3 THOC2 SLC16A7 NIPBL SON

2.70e-058567411M4500
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN

RANBP2 RBBP6 BCLAF1 ZFAND6 HMCES AFF4 RPRD1B SON

2.97e-05432748M41149
CoexpressionMULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP

DST CAPRIN2 ZFAND6 NIPBL AKAP12

3.40e-05130745M6590
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM

SHROOM3 DOCK8 HLF FMN2 DYRK4 EPB41L2

3.48e-05217746M16407
CoexpressionIVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM

SHROOM3 DOCK8 HLF FMN2 DYRK4 EPB41L2

4.59e-05228746MM1014
CoexpressionMURARO_PANCREAS_BETA_CELL

NEFM RANBP2 DST MAP1B ING2 HLF HECTD4 PLCB1 NUCKS1 FMN2 AFF4

6.68e-059467411M39169
CoexpressionCARD_MIR302A_TARGETS

ARID4B MAP1B RBBP6 HLF

6.78e-0577744M2208
CoexpressionNAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE

RANBP2 ZCCHC10 BCLAF1 NUCKS1 THOC2 SLC16A7 AFF4

7.48e-05363747M41103
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN

DST INTS3 SLC16A7 SON

9.52e-0584744M13008
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN

RANBP2 DST INTS3 SON

9.97e-0585744M10575
CoexpressionLAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE

SHROOM3 SH3RF1 PPP1R9A WNK1 SLC16A7

1.25e-04171745M39234
CoexpressionGSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN

ARID4B CCDC47 SEC62 MICAL3 DYNC1I2

1.35e-04174745M6881
CoexpressionDURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS

TGFB1I1 MYLK MAP1B LMOD1

1.41e-0493744M39279
CoexpressionLAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS

DST DOCK8 WNK1 EPB41L2 AKAP12

1.47e-04177745M39245
CoexpressionSRC_UP.V1_UP

LYVE1 LELP1 PI16 FMN2 DYRK4

1.51e-04178745M2714
CoexpressionAIZARANI_LIVER_C20_LSECS_3

LYVE1 MAP1B RBBP6 PLCB1 AFF4 AKAP12

1.88e-04295746M39121
CoexpressionRODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP

RBBP6 BCLAF1 CAST PLCB1 RFC1 THOC2 CWC22 NIPBL AFF4

1.92e-04721749M10237
CoexpressionTRAYNOR_RETT_SYNDROM_UP

PLCB1 SLC16A7 AKAP12

1.98e-0440743M2712
CoexpressionSHEN_SMARCA2_TARGETS_UP

ARID4B ZCCHC10 BCLAF1 SEC62 CAST ZFAND6 SON

2.10e-04429747M29
CoexpressionGSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP

ARID4B AEBP1 RBBP6 SEC62 ZMYND8

2.19e-04193745M4961
CoexpressionGSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN

NEFH RNF168 RBBP6 WNK1 ALPK2

2.30e-04195745M9808
CoexpressionGSE3982_EOSINOPHIL_VS_TH1_UP

CYLC2 PHF20 IDO1 SEC62 LMOD1

2.30e-04195745M5422
CoexpressionPAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN

MYLK MAP1B LMOD1

2.46e-0443743M12432
CoexpressionLIU_SOX4_TARGETS_DN

SHROOM3 RBBP6 BCLAF1 HECTD4 MICAL3 SLC35F5

2.46e-04310746M17287
CoexpressionSMID_BREAST_CANCER_LUMINAL_B_DN

MYCN LYVE1 DST MYLK MAP1B IDO1 MICAL3 EPB41L2

2.48e-04587748M17572
CoexpressionGSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP

MYCN WNK1 NIPBL HMCES DYNC1I2

2.53e-04199745M9600
CoexpressionGSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP

UBR5 DYRK4 RREB1 RWDD4 EPB41L2

2.53e-04199745M7118
CoexpressionGSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP

LETM2 BRD2 PHF20 HECTD4 RREB1

2.53e-04199745M7448
CoexpressionGSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP

ARID4B PHF20 CAPRIN2 ZMYND8 DPY19L4

2.59e-04200745M3251
CoexpressionGSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP

RNF168 NUCKS1 RREB1 RWDD4 RPRD1B

2.59e-04200745M8497
CoexpressionGSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN

DPY19L4 NUCKS1 RFC1 HMCES SON

2.59e-04200745M3199
CoexpressionGSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN

SHROOM3 BRD2 PI16 DOCK8 AFF4

2.59e-04200745M3826
CoexpressionGSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN

SH3RF1 PHF20 CAST PGM2 EPB41L2

2.59e-04200745M5606
CoexpressionTABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING

DST BRD2 MYLK MAP1B AEBP1 LMOD1

3.01e-04322746MM3786
CoexpressionWOOD_EBV_EBNA1_TARGETS_DN

MYLK SLC16A7 AKAP12

3.41e-0448743M19460
CoexpressionCHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS

MYCN LYVE1 RBBP6

3.85e-0450743M1702
CoexpressionBROWNE_HCMV_INFECTION_48HR_DN

TGFB1I1 PHF20 MAP1B LMOD1 DYRK4 SLC16A7 DYNC1I2

4.24e-04482747M12144
CoexpressionKENNY_CTNNB1_TARGETS_DN

UBR5 CCDC47 SEC62

4.32e-0452743M19134
CoexpressionAIZARANI_LIVER_C33_STELLATE_CELLS_2

DST MYLK MAP1B EPB41L2

4.52e-04126744M39132
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

NEFM RANBP2 DST RNF168 MAP1B UBR5 RBBP6 BCLAF1 PPP1R9A HECTD4 FMN2 ZC3H12C

2.17e-066547312Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlasDevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500

DST MYLK MAP1B PI16 DOCK8 HLF CAST LMOD1 SLC16A7

5.80e-06378739gudmap_developingLowerUrinaryTract_adult_bladder_500
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000

TGFB1I1 NEFM LYVE1 DST MYLK MAP1B PI16 DOCK8 CAST LMOD1 EPB41L2 SON

1.21e-057747312gudmap_developingLowerUrinaryTract_P1_bladder_1000_B
CoexpressionAtlasfacebase_RNAseq_e10.5_NeuroEpith_central_2500_K4

MYCN NEFM EFCAB5 CDKL5 SHROOM3 ARID4B MAP1B BCLAF1 CAPRIN2 DPY19L4 ZC3H12C RFC1 CWC22 NIPBL ARHGAP21 DYNC1I2

1.31e-0513707316facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5

NEFM RANBP2 RNF168 MAP1B BCLAF1 FMN2 ZC3H12C

1.50e-05232737Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

NEFM RANBP2 RNF168 MAP1B UBR5 RBBP6 FMN2 ZC3H12C

1.67e-05328738Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

NEFM RANBP2 RNF168 MAP1B UBR5 RBBP6 FMN2 MICAL3 ZC3H12C NIPBL ARHGAP21 AFF4

2.44e-058317312Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000

NEFM RANBP2 RNF168 ARID4B MAP1B UBR5 RBBP6 FMN2 MICAL3 ZC3H12C CWC22 NIPBL ARHGAP21

2.88e-059897313Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500

NEFM LYVE1 DST MYLK MAP1B DOCK8 LMOD1 SLC16A7

5.52e-05388738gudmap_developingLowerUrinaryTract_P1_bladder_500_J
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000

TGFB1I1 NEFM LYVE1 DST MYLK MAP1B PI16 DOCK8 CAST LMOD1 SLC16A7

6.22e-057727311gudmap_developingLowerUrinaryTract_P1_bladder_1000_J
CoexpressionAtlasDevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000

LYVE1 DST MYLK MAP1B PI16 DOCK8 HLF CAST LMOD1 SLC16A7

1.99e-047347310gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500

NEFM RANBP2 RNF168 MAP1B BCLAF1 FMN2 ZC3H12C CWC22

2.86e-04493738Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000

LYVE1 DST MYLK MAP1B PI16 DOCK8 CAST LMOD1 SLC16A7 AKAP12

3.04e-047747310gudmap_developingLowerUrinaryTract_P1_ureter_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

NEFM RNF168 MAP1B UBR5 FMN2 ZC3H12C CWC22 NIPBL

3.06e-04498738Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500

LYVE1 DST MYLK MAP1B PI16 DOCK8 SLC16A7

3.84e-04390737gudmap_developingLowerUrinaryTract_P1_ureter_500
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_1000

BRD2 AEBP1 RFC1 NIPBL EPB41L2

4.00e-04181735gudmap_developingGonad_e14.5_ testes_1000_k2
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000

MYCN NEFM BRD2 SH3RF1 PHF20 BCLAF1 RFC1 RREB1 THOC2 EPB41L2

4.19e-048067310gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlasdev gonad_e11.5_F_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_500

SHROOM3 ING2 CWC22

4.36e-0443733gudmap_dev gonad_e11.5_F_GonMes_Sma_k1_500
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

SHROOM3 DST MAP1B IDO1 BCLAF1 NUCKS1 RFC1 NIPBL

1.49e-09199748c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 PLCB1 LMOD1 MICAL3 AKAP12

1.49e-09199748b1753474152b82a0b811b9878c890a359e14919a
ToppCell343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells)

TGFB1I1 DST MYLK MAP1B AEBP1 PI16 LMOD1 AKAP12

1.55e-09200748376c1a77031e090be96948b47c78ac0d393f5775
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 NEFM MYLK MAP1B PLCB1 LMOD1 EPB41L2

1.87e-08177747452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCellIPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class

TGFB1I1 LYVE1 MYLK MAP1B AEBP1 LMOD1 AKAP12

2.83e-08188747e98b24c0de41285f01f7ac194ff0a1b59fd5c333
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DST MYLK MAP1B HLF AFF4 EPB41L2 SON

3.04e-08190747d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ARID4B UBR5 PPP1R9A PLCB1 WNK1 NIPBL AFF4

3.26e-08192747916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

ARID4B UBR5 PPP1R9A PLCB1 WNK1 NIPBL AFF4

3.38e-08193747e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DST MYLK MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

3.50e-0819474790efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DST MYLK MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

3.50e-08194747df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCellParenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MYLK MAP1B AEBP1 PLCB1 LMOD1 MICAL3 AKAP12

4.03e-08198747bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCellILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TGFB1I1 SHROOM3 MYLK MAP1B AEBP1 LMOD1 AKAP12

4.17e-081997473368c0a90a47c4dcdfe70be3192550df0744e508
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DST MYLK MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

4.32e-08200747389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ARID4B DOCK8 BCLAF1 CAST NIPBL AFF4 SON

4.32e-0820074712f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellPericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

MYLK MAP1B AEBP1 PLCB1 LMOD1 AKAP12

1.91e-07150746dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 NEFM EFCAB5 MYLK MAP1B LMOD1

5.05e-07177746d731400997afea379f47ae8aa0f82802962b0861
ToppCellCOPD-Stromal-SMC|COPD / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

5.40e-071797465c705627bd13a5b2c7b0062fb3d94e4eb1589327
ToppCellCOPD-Stromal-SMC|World / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

5.40e-07179746b2709537ec1b46457ab85261f4cdd354e60a8b29
ToppCellControl-Stromal-SMC|Control / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

5.40e-071797461378051bc62009eec2dbecf3d5d89baedbeb84eb
ToppCell3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 FMN2 LMOD1

5.76e-07181746ab0f300d14b62cef57f1b0bdae143b8dfe8e6975
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

6.14e-0718374661a73de857f4ae02dcba3af348f436f602b28ff2
ToppCellControl-Stromal-SMC|World / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

6.34e-0718474688b1a4c9a96a99fc3a39f7a2c3d0838739606f3e
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

6.34e-071847465cfc19ffb9f074bdf0d81c86e212a708ec141631
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK AEBP1 FMN2 LMOD1 AKAP12

6.34e-07184746590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCellnucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

6.75e-07186746c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80
ToppCellIPF-Stromal-SMC|World / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

7.19e-07188746b66264e8f8d536ed2beec31e6746c687718f239b
ToppCelldroplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BRD2 ARID4B MAP1B SEC62 NIPBL SON

7.19e-07188746d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B FMN2 LMOD1 AKAP12

7.19e-07188746879de94924de978478696fc7838e05a4d795b905
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B FMN2 LMOD1 AKAP12

7.42e-07189746ab7ece0a517499b70b7754720d3e434765363af6
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

7.42e-07189746f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0
ToppCell3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

7.42e-0718974663449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DST MYLK AEBP1 PLCB1 LMOD1 EPB41L2

7.89e-07191746806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B PLCB1 LMOD1 EPB41L2

7.89e-071917461626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B PLCB1 LMOD1 EPB41L2

7.89e-07191746716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

8.38e-071937469104b572d9c3c99080e4b7455993fbb944bf117d
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RANBP2 ARID4B BCLAF1 NIPBL AKAP12 SON

8.64e-07194746e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCellnucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TGFB1I1 MYLK MAP1B AEBP1 PLCB1 LMOD1

8.64e-071947462d66091097e106c7bee22e5281f50724700bdf8d
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DST MAP1B SEC62 RFC1 AKAP12 SON

8.64e-071947468985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 PLCB1 LMOD1

8.64e-07194746f5e3e675187afb6efa774f2a8d685efcf813de82
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DST MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

8.90e-07195746d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCellfacs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TGFB1I1 SHROOM3 MYLK MAP1B AEBP1 LMOD1

8.90e-0719574621cfcb751e548591fc8724a8329c294da6012e0f
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

8.90e-071957466524ee7bdc70bb5955dd6a6f134a8e6d8b5f2b39
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-07196746f78951b460913866d092ba92af70ea76a2afa73e
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-07196746ac4c8571bd792538f8df7b9bdd90ef58405fd3b1
ToppCellControl-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class

LYVE1 DST MAP1B DOCK8 MICAL3 AKAP12

9.17e-07196746e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-0719674669ad90a429af4dad5a45556544224001ebcb1607
ToppCellIPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-071967468b6ff47ce5291d223f5e639fc45cd9267f418256
ToppCellCOVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type

TGFB1I1 MYLK MAP1B AEBP1 PLCB1 LMOD1

9.17e-07196746754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-0719674620dc9b25ecc23b6e6e52bbab8b5a404f3245ca37
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-071967464da96672a9c72268cfcc82d61eb3caae6e02d4c4
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.17e-0719674670b2e0b4ff4f1bc03fb72ace07a8a44f4b415922
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 PLCB1 LMOD1

9.44e-0719774601249bd485a3734de87ae6ed9c749597f39c6335
ToppCellParenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.44e-071977463f078be0b0f5e16edfb6d517beb20ac6178767f0
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

9.73e-07198746705118a5db366b43ffd3389c60e4cb392ad3f2e6
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

SHROOM3 IDO1 RBBP6 CCDC47 BCLAF1 NIPBL

9.73e-0719874676d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 PI16 LMOD1

9.73e-071987464961a3e9b953679648586afed04869ff36b81820
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 NEFM MYLK MAP1B AEBP1 LMOD1

1.00e-061997468ff0fdcbe9661b013913731ec8b53d84836ca865
ToppCellParenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

1.00e-0619974620f760d92c351a1dac4cc0a424c443ea03a179fe
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

ARID4B RBBP6 BCLAF1 SLC35C1 THOC2 NIPBL

1.00e-06199746fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

1.00e-06199746ad75e5e26c37a97331164d7f77235ebd9a933a44
ToppCellParenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

1.00e-061997467c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCellCOVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type

DST MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

1.00e-061997469503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

RBBP6 BCLAF1 RFC1 THOC2 NIPBL AKAP12

1.00e-06199746a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

TGFB1I1 MYLK MAP1B PLCB1 LMOD1 EPB41L2

1.03e-06200746d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell(5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

TGFB1I1 DST MYLK MAP1B AEBP1 AKAP12

1.03e-0620074622c839f27d3abdf86bfabdfa305f205dd899a9dc
ToppCell3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MAP1B AEBP1 PI16 LMOD1 AKAP12

1.03e-06200746ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833
ToppCellBiopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

1.03e-0620074655ac281901309e30978da1f7489386e54489721e
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TGFB1I1 MYLK MAP1B PLCB1 LMOD1 EPB41L2

1.03e-06200746786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCellCOVID-19|World / Disease, condition lineage and cell class

ARID4B RBBP6 BCLAF1 NIPBL AFF4 SON

1.03e-062007467dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellBiopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type

TGFB1I1 MYLK MAP1B AEBP1 LMOD1 AKAP12

1.03e-06200746d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEFH AEBP1 FMN2 ALPK2 AKAP12

6.24e-06156745dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NEFH AEBP1 FMN2 ALPK2 AKAP12

6.24e-06156745abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK FMN2 LMOD1 AKAP12

9.75e-06171745fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor

MYLK MAP1B PLCB1 LMOD1 MICAL3

1.00e-05172745c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYLK MAP1B PLCB1 LMOD1 MICAL3

1.03e-051737455416b092321c7d9b63f0418c60f2402a138355bf
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.03e-05173745ecbf7167d4bec685e3460d826318544946f5f5c2
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.03e-05173745b8dc978c52de64afba21ff6cb32e79f07167448e
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.09e-05175745c6c0196875f3b5293083cda6718300806a801941
ToppCellNS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TGFB1I1 LYVE1 MAP1B AEBP1 AKAP12

1.09e-05175745f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.09e-0517574582c4d1edaa0d3b82d3ef4676d6f6516104a2656a
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK AEBP1 FMN2 LMOD1

1.12e-05176745a8875b4ba4abf6625cdeb67bf544ce1573c59060
ToppCellControl-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations)

LYVE1 MAP1B PLCB1 EPB41L2 AKAP12

1.12e-0517674598c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCellControl-Neuronal_cells|Control / group, cell type (main and fine annotations)

LYVE1 MAP1B PLCB1 EPB41L2 AKAP12

1.12e-05176745c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYLK MAP1B AEBP1 ING2 LMOD1

1.15e-0517774588403b055eb9fdf96e4695fb6e0d78179e30a1e3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYLK MAP1B AEBP1 ING2 LMOD1

1.15e-051777458903aeaab61abd81a148ea623038c5114b8a183b
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B AEBP1 LMOD1 EPB41L2 AKAP12

1.18e-05178745d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

MYLK MAP1B AEBP1 LMOD1 AKAP12

1.25e-05180745d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellPericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

TGFB1I1 MAP1B AEBP1 LMOD1 AKAP12

1.28e-05181745ff445a8e56522e57e27405184d123cf905caf8cc
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TGFB1I1 ING2 HLF HECTD4 EPB41L2

1.28e-051817459275531e896e118cee043ed94fd31a0070d9581c
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 DST MYLK LMOD1 AKAP12

1.28e-05181745beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TGFB1I1 ING2 HLF HECTD4 EPB41L2

1.32e-0518274521744c9c792e57d5d41b25986f419b2358c7057b
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.32e-0518274597bb07478f56a937b490fba121ee603db64134a1
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.32e-051827451c1a687f728341c209b048b6715bcddd0ac20069
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LYVE1 DST MAP1B EPB41L2 AKAP12

1.35e-051837454d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

DST ARID4B IDO1 RBBP6 AFF4

1.35e-051837458f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TGFB1I1 MYLK MAP1B LMOD1 AKAP12

1.35e-051837456b5eef96b28911c752a8b6c0975918c4572cec38
ToppCellCOPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class

TGFB1I1 MYLK MAP1B AEBP1 AKAP12

1.39e-05184745a56264a22dfc2d3672b20134ab7c3c7c23da5ae1
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.39e-05184745603faafb7b289a3c0242c84fc800c050c8a092ea
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TGFB1I1 MYLK MAP1B AEBP1 LMOD1

1.39e-05184745c350504bfe0ec31cd2fc2199de9b5fff151a8c5e
ToppCellcellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TGFB1I1 DST MYLK MAP1B LMOD1

1.43e-0518574576304829fcfb5934188933ca20d33bc8c8b0dc91
Drugallyl chloride

NEFM NEFH LMOD1

3.73e-0610733CID000007850
DrugAC1O5Y0F

NEFM NEFH ARID4B MAP1B

5.93e-0637734CID006442852
Drug1,2-dithiol-3-thione

USP14 LYVE1 MAP1B UBR5 DOCK8 BCLAF1 SEC62 CAST PLCB1 ZFAND6 DYNC1I2 AKAP12

1.20e-058297312ctd:C049325
DiseaseMegacystis microcolon intestinal hypoperistalsis syndrome

MYLK LMOD1

3.61e-054732C1608393
Diseasebody weight

CYLC2 SH3RF1 HLF HECTD4 CAST NUCKS1 CWC22 SLC16A7 NIPBL HMCES DYNC1I2 EPB41L2

5.80e-0512617312EFO_0004338
Diseasemegacystis-microcolon-intestinal hypoperistalsis syndrome (is_implicated_in)

MYLK LMOD1

6.01e-055732DOID:0060610 (is_implicated_in)
Diseasesmoking status measurement, chronic obstructive pulmonary disease

EFCAB5 ZCCHC10 MICAL3 RREB1

6.87e-0588734EFO_0000341, EFO_0006527
Diseasecongenital hypothyroidism (implicated_via_orthology)

NEFM NEFH

5.39e-0414732DOID:0050328 (implicated_via_orthology)
Diseasecolorectal cancer

CAPRIN2 ZBTB40 PLCB1 FMN2 LMOD1 RREB1 WNK1

7.37e-04604737MONDO_0005575
Diseasevital capacity

USP14 SHROOM3 DST CAPRIN2 ZBTB40 PLCB1 NUCKS1 MICAL3 RREB1 EPB41L2

9.05e-0412367310EFO_0004312
Diseasehypothyroidism (biomarker_via_orthology)

NEFM NEFH MAP1B

1.04e-0380733DOID:1459 (biomarker_via_orthology)
DiseaseWest Syndrome

CDKL5 PLCB1

1.61e-0324732C0037769
Diseasesciatic neuropathy (biomarker_via_orthology)

NEFM NEFH AKAP12

1.92e-0399733DOID:11446 (biomarker_via_orthology)
DiseaseAdenoid Cystic Carcinoma

MYCN ARID4B SON

1.98e-03100733C0010606
DiseaseBone Diseases, Developmental

NIPBL AFF4

2.04e-0327732C0005941
DiseaseDrugs affecting bone structure and mineralization use measurement

ZBTB40 FMN2

2.35e-0329732EFO_0009936

Protein segments in the cluster

PeptideGeneStartEntry
PKSADKVTDKTKVPS

PI16

316

Q6UXB8
DVKKDTTDKSSKPQI

ARID4B

806

Q4LE39
SHTEEKQDPKKPSCK

ALPK2

1766

Q86TB3
ASKESEPKQSTEKPE

AKAP12

226

Q02952
EKQEKEPSKSAESPT

AKAP12

271

Q02952
KPKKEDSSPKEETDK

AEBP1

341

Q8IUX7
KPSSTDSDSKDDVKK

CYLC2

276

Q14093
ASESKKPKTEDKNSA

AFF4

776

Q9UHB7
KPLSIKEKPSTEKES

CCNB3

416

Q8WWL7
KEKPSTEKESFSQEP

CCNB3

421

Q8WWL7
KAKEKKKPEDSPSDD

RANBP2

2616

P49792
SASEEEDTKPKPTKR

INTS3

1016

Q68E01
EKPPENQKKLSDKDT

IQCF1

56

Q8N6M8
KASKEKTPSPKEEDE

NUCKS1

196

Q9H1E3
QPKENKTSEDPSKLE

IDO1

361

P14902
KSKSNDPKTEPKNCD

LELP1

6

Q5T871
PSTFESESKKEEKQK

LETM2

206

Q2VYF4
TESDATVKKKPAPKT

MYLK

1216

Q15746
KKKKADDKSCPSTPS

MICAL3

1751

Q7RTP6
DKPIKTETKPSVTEK

MAP1B

591

P46821
PKDAKKSSTPLSEAK

MAP1B

736

P46821
ESKKTDKNPEESKSP

LYVE1

296

Q9Y5Y7
FKETEIPPKETEKSK

DST

316

Q03001
SSSAQDEPATKKKKD

CWC22

106

Q9HCG8
KTLKKDEENDSKAPP

DYNC1I2

191

Q13409
EDKPDTSSSKNKDPI

CCDC47

106

Q96A33
EKPSVSKEEKPSVSK

EPB41L2

146

O43491
EAKDDSKTKTPEKQT

LMOD1

281

P29536
PSTEKKPEVSKHKQD

NIPBL

771

Q6KC79
DDSQPDKKAVLPTSK

PGM2

526

Q96G03
KSKNKTGKTEDDSSP

SLC16A7

206

O60669
KEKKLDDESNSPTVP

HLF

46

Q16534
SPEKSKPDEKDPEKS

HECTD4

3381

Q9Y4D8
EDCDDQPPKEKKSKS

ING2

171

Q9H160
KAKEETPKTDNTKSS

RBBP6

1061

Q7Z6E9
SPEKEAKSPVKEEAK

NEFH

511

P12036
KEEAKSPAEAKSPEK

NEFH

521

P12036
SPAEAKSPEKEEAKS

NEFH

526

P12036
KSPEKEEAKSPAEVK

NEFH

531

P12036
SPEKAKSPAKEEAKS

NEFH

546

P12036
SPEKEEAKSPAEVKS

NEFH

566

P12036
EVKSPEKAKSPTKEE

NEFH

631

P12036
EKAKSPTKEEAKSPE

NEFH

636

P12036
KAKSPEKAKSPEKEE

NEFH

651

P12036
EKAKSPEKEEAKSPE

NEFH

656

P12036
SPEKAKSPVKEEAKS

NEFH

696

P12036
EEAKSPEKAKSPVKE

NEFH

706

P12036
SPVKEEAKSPEKAKS

NEFH

716

P12036
EAKSPEKAKSPVKEE

NEFH

721

P12036
EKAKSPVKEEAKTPE

NEFH

726

P12036
VKEEAKSPEKAKSPE

NEFH

746

P12036
KKAEEEKAPATPKTE

NEFH

846

P12036
EKAPATPKTEEKKDS

NEFH

851

P12036
AKEDDKTLSKEPSKP

NEFH

981

P12036
EPSKPKAEKAEKSSS

NEFH

991

P12036
EKSSSTDQKDSKPPE

NEFH

1001

P12036
TDQKDSKPPEKATED

NEFH

1006

P12036
KKTPEEPSPKDSEKS

SLC35C1

346

Q96A29
SIKTQDPKAEEKSPK

DYRK4

16

Q9NR20
PETTKKEVQKDKPCE

EFCAB5

731

A4FU69
KDSTPVDKTKLDPNK

DOCK8

1846

Q8NF50
ESPLKSKSQEEPKDT

BCLAF1

176

Q9NYF8
KPKSSENKESAKEEK

DPY19L4

16

Q7Z388
EQKKQEISKSKPSPS

CAPRIN2

456

Q6IMN6
CKEKPSKPTEKTEES

CAST

381

P20810
KKSEDSKKPADDQDP

CAST

636

P20810
KKKKSQTVPNSDSPD

CDKL5

786

O76039
SSKDKENAKSLDKPE

FMN2

1421

Q9NZ56
KASPEPEKDFSEKAK

ZMYND8

666

Q9ULU4
LATKSPKKEDSKTPQ

HMCES

291

Q96FZ2
PKKEDSKTPQKEESD

HMCES

296

Q96FZ2
PAKENPNEKKLSESS

MDFIC2

61

A0A1B0GVS7
SASSPTTKDKEKNKE

PHF20

516

Q9BVI0
DSKSPPPKATEEKKS

RPRD1B

131

Q9NQG5
EKPESTNIDTEKTPK

SLC35F5

176

Q8WV83
PAKKESVSPEDSEKK

RFC1

361

P35251
KEEATSNSPSKESKK

TAF1L

536

Q8IZX4
LEKKVSPDPQKSSED

SHROOM3

1651

Q8TF72
GNSSATKPDKDSKKE

SH3RF1

701

Q7Z6J0
KKPPKKANEKTESSS

BRD2

751

P25440
KETSECPSDKDKSPE

C10orf62

11

Q5T681
EKEKEKKEKTPATTP

THOC2

1276

Q8NI27
SEDAPPQKKIKSEAS

MYCN

341

P04198
EKEESKKEETPGTPK

SEC62

146

Q99442
SEKSDDDKKPKTDSP

RREB1

1486

Q92766
DDKKPKTDSPKSVAS

RREB1

1491

Q92766
ETPNTAPSSKKKDKK

RWDD4

131

Q6NW29
PSEEQSKSLEKPKQK

ZFAND6

131

Q6FIF0
KKDSKKKSEPSSPDH

PLCB1

971

Q9NQ66
SRKSDPVTPKSEKKS

RNF168

201

Q8IYW5
STDSSSDDEPPKKKK

ZCCHC10

176

Q8TBK6
KEDQSEDKKRPSLPS

TGFB1I1

126

O43294
KPEESQTTSKEAKKP

ZC3H12C

141

Q9C0D7
SKTEDKITDTKKEGP

WNK1

1961

Q9H4A3
PNTSDKKSSPQKEVK

USP14

386

P54578
RKKPKEKAQPSSSED

ARHGAP21

1421

Q5T5U3
QTDPTDEIPTKKSKK

SON

96

P18583
EKASKTTEAKPESKQ

UBR5

586

O95071
QEKEASASPDPAKKS

ZBTB40

721

Q9NUA8
KSTFDKPKSDGEQKT

PPP1R9A

31

Q9ULJ8
KSPVSKSPVEEKAKS

NEFM

666

P07197